BRAVA & RIZA Advocates offers comprehensive legal support to clients operating in the healthcare and life sciences sector, one of the most highly regulated industries in Indonesia. Our Healthcare practice is designed to help healthcare providers, pharmaceutical companies, medical device manufacturers, and health-tech innovators navigate complex regulatory frameworks while advancing patient-centered, commercially sustainable operations.

​

Our team is experienced in advising companies operating across the value chain, from upstream land acquisition and licensing to downstream processing and distribution, ensuring legal compliance while protecting long-term commercial interests. We understand the complex interplay of environmental, agrarian, corporate, and trade laws that govern these industries and provide solutions that are legally sound, commercially practical, and aligned with sustainability goals.

​

We assist both local and international companies in handling a wide range of employment matters, including hiring and compliance, dispute resolution, and workforce restructuring. Whether you’re expanding operations, managing employee relations, or responding to new labor regulations, we offer practical solutions that protect your business and support your people.

​

Our services include:

​

• Structuring and negotiating joint ventures, acquisitions, and investments.

• Assisting with land acquisition, community engagement, and conflict resolution.

• Drafting and reviewing operational contracts, including processing, transport, and export agreements.

• Representing clients in administrative disputes and regulatory enforcement actions.

• Resolving land and resource disputes, including overlaps with indigenous and local communities; and

• Other forestry & plantation-related matters.

​

We also support clients in responding to policy changes and managing reputational risk. With increasing global attention on responsible sourcing and environmental impact, our lawyers help clients meet evolving standards while maintaining operational stability and investor confidence.